AccueilVeille ScientifiqueCeftolozane-tazobactam Versus Meropenem for Treatment of Nosocomial Pneumonia (ASPECT-NP): A Randomised, Controlled, Double-Blind, Phase 3, Non-Inferiority Trial

Lancet Infect Dis • 2019.09.25

Kollef M.H.,  Nová?ek M.,  Kivistik Ü., et al.